Abigail (Lauterbach) Schmitz
Senior Associate
RA Capital Management
TechAtlas senior associate evaluating biotech opportunities and competitive landscapes.
Bio
Professional summary
Matt Renna is a Managing Partner at Westfield Capital Management and a member of its Investment Committee, responsible for research coverage of Biopharma & Life Sciences. He previously served as a Health Care Portfolio Manager at Vinik Asset Management, Director on BlackRock's SMID Growth Equity team, and Senior Equity Analyst at RA Capital Management. He began his career in health care at Merck before moving into equity research at Leerink Swann.
Background
Career, education, and skills
Career history
- Westfield Capital ManagementManaging Partner / Health Care Sector Head2013 – Present
- Vinik Asset ManagementHealth Care Portfolio Manager2012 – 2013
- BlackRockDirector, SMID Growth Equity2009 – 2012
- RA Capital ManagementSenior Equity Analyst2008 – 2009
- Soleil Securities Corporation / Neponset Equity ResearchDirector, Healthcare/Biotechnology2005 – 2008
- Leerink SwannSenior Research Associate2004 – 2005
- Merck & Co.Health Care Industry Role2001 – 2004
Education
- Boston College Carroll School of ManagementMBA2006
- Boston UniversityMS2001
- Boston UniversityBS1999
Other partners at RA Capital Management
12 more profiles
Adam Prince, MD
Senior Associate, Strategic Initiatives
RA Capital Management
RA Capital TechAtlas senior associate with cardiology and medical training.
Alana MacDonald, Ph.D.
Senior Associate
RA Capital Management
Senior TechAtlas associate focused on biotech diligence, landscapes, and portfolio strategy.
Alejandro Sevilla
Associate
RA Capital Management
Planetary Health associate focused on climate-tech landscapes and investment evaluation.
Alex Miller
Senior Associate, Venture
RA Capital Management
Venture senior associate focused on biotech diligence and portfolio strategy.
Alex T. Zhang
Vice President, Structured Capital
RA Capital Management
Structured Capital VP focused on healthcare and life-sciences credit investments.
Alexander Martinez-Forte
Director, Quantitative Research & Strategy
RA Capital Management
RA Capital director leading quantitative analyses for investment decisions and portfolio management.
Allison Harrigan
Senior Director Corporate Development
RA Capital Management
Raven corporate development leader focused on biotech company creation.
Alyssa Larson
Director, Healthcare Specialist - Investor Relations
RA Capital Management
TechAtlas director supporting healthcare diligence and investor relations.
Ami Thakrar, PhD
Associate
RA Capital Management
TechAtlas associate focused on biotech diligence and program strategy.
Anish K. More
Vice President, Corporate Development
RA Capital Management
Raven corporate-development VP focused on investment evaluation and NewCo creation.
Anurag Kondapalli
Principal
RA Capital Management
Principal investing across public and private healthcare technology and services companies.